Pila Pharma AB (publ) 5KC.F Stock
0.51 EUR
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
12.13M EUR
LOW - HIGH [24H]
0.51
-
0.57 EUR
VOLUME [24H]
500 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.04 EUR
Pila Pharma AB (publ) Price Chart
Pila Pharma AB (publ) 5KC.F Financial and Trading Overview
| Pila Pharma AB (publ) stock price | 0.51 EUR |
| Previous Close | 0.24 EUR |
| Open | 0.2 EUR |
| Bid | 0.2 EUR x N/A |
| Ask | 0.28 EUR x N/A |
| Day's Range | 0.2 - 0.2 EUR |
| 52 Week Range | 0.17 - 0.5 EUR |
| Volume | 100 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 3.8M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
5KC.F Valuation Measures
| Enterprise Value | 4.4M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.362069 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Pila Pharma AB (publ) Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -22.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.5 EUR |
| 52 Week Low | 0.17 EUR |
| 50-Day Moving Average | 0.21 EUR |
| 200-Day Moving Average | 0.25 EUR |
5KC.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 18.41M |
| Float | 8.96M |
| Short Ratio | N/A |
| % Held by Insiders | 45.75% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 111.71% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.82% |
| Return on Equity (ttm) | -160.95% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 48.79% |
| Gross Profit (ttm) | 1.88M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.835 |
| Book Value Per Share (mrq) | 0.145 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Pila Pharma AB (publ)
| Country | Germany |
| State | N/A |
| City | Malmö |
| Address | Norra Vallgatan 72 |
| ZIP | 211 22 |
| Phone | 46 7 39 03 69 69 |
| Website | https://pilapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2b clinical trials for type 2 diabetes. The company was incorporated in 2014 and is based in Malmö, Sweden.
Q&A For Pila Pharma AB (publ) Stock
What is a current 5KC.F stock price?
Pila Pharma AB (publ) 5KC.F stock price today per share is 0.51 EUR.
How to purchase Pila Pharma AB (publ) stock?
You can buy 5KC.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pila Pharma AB (publ)?
The stock symbol or ticker of Pila Pharma AB (publ) is 5KC.F.
Which industry does the Pila Pharma AB (publ) company belong to?
The Pila Pharma AB (publ) industry is Biotechnology.
How many shares does Pila Pharma AB (publ) have in circulation?
The max supply of Pila Pharma AB (publ) shares is 23.79M.
What is Pila Pharma AB (publ) Price to Earnings Ratio (PE Ratio)?
Pila Pharma AB (publ) PE Ratio is now.
What was Pila Pharma AB (publ) earnings per share over the trailing 12 months (TTM)?
Pila Pharma AB (publ) EPS is -0.04 EUR over the trailing 12 months.
Which sector does the Pila Pharma AB (publ) company belong to?
The Pila Pharma AB (publ) sector is Healthcare.